These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8981077)

  • 1. Pharmacological activity of the new calcium antagonist, lacidipine, on isolated preparations.
    Raddino R; Metra M; Nodari S; Pelá G; Fappani A; Dei Cas L
    Gen Pharmacol; 1996 Oct; 27(7):1255-9. PubMed ID: 8981077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial and vascular effects of efonidipine in vitro as compared with nifedipine, verapamil and diltiazem.
    Tanaka H; Masumiya H; Sekine T; Sijuku T; Sugahara M; Taniguchi H; Terada M; Saito W; Shigenobu K
    Gen Pharmacol; 1996 Apr; 27(3):451-4. PubMed ID: 8723524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative determination of the cardioselectivity of taxine and verapamil in the isolated aorta, atrium and jejunum preparations of rabbits.
    Tekol Y; Göğüsten B
    Arzneimittelforschung; 1999 Aug; 49(8):673-8. PubMed ID: 10483513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hemodynamic effects of lacidipine in anesthetized dogs: comparison with nitrendipine, amlodipine, verapamil, and diltiazem.
    Quartaroli M; Gambini F; Tarter G; Micheli D; Trist DG; Gaviraghi G
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):326-36. PubMed ID: 1720831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
    Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P
    J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles.
    Nishimura K; Miyawaki N; Yamauchi H; Iso T
    Arzneimittelforschung; 1990 Mar; 40(3):244-8. PubMed ID: 2112000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
    Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory actions of amiodarone on the isolated rabbit heart and aorta.
    Raddino R; Poli E; Pelà G; Gargano M; Manca C
    Gen Pharmacol; 1989; 20(3):313-7. PubMed ID: 2744397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilatory action of amlodipine on rat aorta, pig coronary artery, human coronary artery, and on isolated Langendorff rat heart preparations.
    Matlib MA; French JF; Grupp IL; Van Gorp C; Grupp G; Schwartz A
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S50-4. PubMed ID: 2467129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cyclic GMP in inhibitory effects of CD-349 in isolated blood vessels.
    Miyata N; Yamaura H; Tsuchida K; Otomo S; Miyajima E
    Gen Pharmacol; 1994 Mar; 25(2):267-73. PubMed ID: 8026725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of S-312, a new calcium antagonist, on the mechanical and electrophysiological responses of isolated cardiovascular preparations.
    Ninomiya M; Tani T; Nakajima S; Ueda M
    Jpn J Pharmacol; 1989 Oct; 51(2):227-38. PubMed ID: 2593380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic and antiischemic effects of nifedipine, lacidipine, and nisoldipine in rat isolated working heart.
    Pijl AJ; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):381-7. PubMed ID: 7504127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects of the new calcium antagonist lacidipine.
    Kawada T; Sun HT; Nakazawa M; Imai S
    Jpn J Pharmacol; 1993 Jul; 62(3):289-96. PubMed ID: 8411776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-heterotricyclic substituted 1,4-dihydropyridines with a potent selective bradycardic effect.
    Rampa A; Chiarini A; Bisi A; Budriesi R; Valenti P
    Arzneimittelforschung; 1991 Jul; 41(7):705-9. PubMed ID: 1772458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac inotropic vs. chronotropic selectivity of isradipine, nifedipine and clevidipine, a new ultrashort-acting dihydropyridine.
    Segawa D; Sjöquist PO; Nordlander M; Wang QD; Gonon A; Rydén L
    Eur J Pharmacol; 1999 Sep; 380(2-3):123-8. PubMed ID: 10513571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the calcium channel facilitator, CGP 28,392, on different modes of contraction in smooth muscle of rabbit and rat aortae and guinea-pig taenia caeci.
    Karaki H; Nagase H; Ozaki H; Urakawa N; Weiss GB
    Br J Pharmacol; 1986 Oct; 89(2):423-9. PubMed ID: 3779218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the novel calcium channel blocker, anipamil, on the isolated rabbit heart. Comparison with verapamil and gallopamil.
    Raddino R; Poli E; Pasini E; Ferrari R
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):339-44. PubMed ID: 1383837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SAR studies in the field of Ca-antagonists: 2-substituted 1,4-dihydropyridines with a xanthone backbone.
    Bisi A; Budriesi R; Chiarini A; Rampa A; Valenti P
    Farmaco; 1993 Nov; 48(11):1491-502. PubMed ID: 8110362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characteristics of NP-252, a new dihydropyridine slow Ca2+ channel blocker, in isolated rabbit vascular smooth muscle and guinea pig myocardium: vascular selectivity.
    Shibata S; Satake N; Kodama I; Hester RK; Wang CG; Jino H; Hojo M; Tatsumi H; Gandhi V; Jones DJ
    Eur J Pharmacol; 1991 Oct; 203(3):337-44. PubMed ID: 1773820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.